NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,166 filers reported holding NOVARTIS A G in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $217,764 | +7.8% | 2,158 | -3.1% | 0.05% | -8.8% |
| Q4 2022 | $201,943 | -11.4% | 2,226 | -11.1% | 0.06% | -13.6% |
| Q2 2021 | $228,000 | +14.0% | 2,503 | +18.1% | 0.07% | -7.0% |
| Q4 2020 | $200,000 | -10.3% | 2,119 | -10.1% | 0.07% | -25.3% |
| Q4 2019 | $223,000 | -18.3% | 2,356 | -17.1% | 0.10% | -28.6% |
| Q1 2019 | $273,000 | +11.0% | 2,842 | -0.9% | 0.13% | -10.7% |
| Q4 2018 | $246,000 | – | 2,868 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |